QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 benzinga-expands-footprint-into-the-psychedelic-industry-with-the-launch-of-the-benzinga-psychedelic-advisory-council

DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voic...

 novamind-posts-record-high-revenue-of-ca245m-up-32-qoq

Psychedelics-focused mental health company Novamind Inc. (CSE:NM) (OTCQB: NVMDF) (FSE: HN2) reported its financial results for ...

 benzingas-unprecedented-psychedelics-investing-conference-lands-in-miami-on-april-19th

The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking...

 novamind-to-host-clinical-trial-to-advance-ketamine-therapy-for-end-of-life-patients

Mental health company specialized in psychedelic medicine Novamind Inc. (CSE:NM) (OTCQB: NVMDF) (FSE:HN2) has been selected by ...

 novamind-stock-dives-on-395m-private-placement-with-institutional-investor

Novamind Inc. (CSE: NM) (OTCQB: NVMDF) (FSE: HN2) announced Monday a CA$5 million ($3.95 million) private placement with an ins...

 psychedelic-medicine-major-health-providers-including-blue-cross-now-cover-ketamine-treatments

Four major health insurance providers recently approved psychedelic medicine company Novamind Inc. (CSE: NM) (OTCQB: NVMDF) for...

 psyched-field-trip-uplists-to-nasdaq-mindmed-to-study-dmt-atai-launches-new-subsidiary-aocs-psychedelics-amendment-rejected

Last week in Psychedelics:

 cannabis-countdown-top-10-marijuana-and-psychedelic-stock-news-stories-of-the-week

Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock Ne...